Jul 14, 2021 9:00am EDT CohBar Provides Update on the Phase 1a/1b Clinical Trial for CB4211 Under Development for NASH and Obesity
May 17, 2021 4:02pm EDT CohBar Reports First Quarter 2021 Financial Results and Provides Business Update
May 03, 2021 9:00am EDT CohBar to Announce 2021 First Quarter Financial Results and Provide Business Update on May 17, 2021
Apr 27, 2021 8:30am EDT CohBar Appoints Joseph J. Sarret, M.D., J.D. as Chief Executive Officer and Director
Apr 21, 2021 9:00am EDT CohBar Completes Last Subject Visit in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
Mar 30, 2021 4:02pm EDT CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update
Mar 29, 2021 9:00am EDT CohBar Completes Enrollment in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
Mar 16, 2021 4:05pm EDT CohBar to Announce 2020 Fourth Quarter Financial Results and Provide Business Update on March 30, 2021